Important message from the Chairman & CEO
March 14, 2022
Dear Shareholders,
It is an exciting time for ORHub. Our vision for the Company began in the operating room where we identified opportunities to improve the business relationship shared between hospital and medical device / biotech companies that ultimately impact a patient’s surgical experience. Our mindset on Changing Business for Good™ will not waiver and will continue to guide our business design and strategy, while remaining focused on helping deliver sustainable healthcare and future innovation.
ORHub has made significant progress on all fronts: removing distractions, continuing relevant filings, reducing debt, and ongoing preparation for an audit. We have made a significant investment to develop and recently completed the long-awaited FutureOR™ software, designed to deliver efficiency for hospital operating rooms and participating biological & medical device vendors. FutureORTM enables new digital processes to increase payment speed with these manufacturers, while controlling cost and accuracy for the hospitals. ORHub is in continued discussions to acquire, merge, or partner with strategic businesses that fit our vision in healthcare technologies. Our goal with these transactions, is to achieve fast and profitable growth using current product and opportunities with highly scalable potential with our market channels and leverage.
ORHub has entered a LOI and is pursuing an acquisition of PUR Biologics, an ortho-biologic company. PUR brings a product portfolio for bone regeneration and a patent portfolio including interests in regenerating mature hyaline cartilage, skin health & aesthetics. PUR’s research explores novel changes to how we address chronic pain, osteoarthritis, and a potentially significant neurological application.
Along with our new website, which is being prepared by branding professionals, ORHub is reestablishing its social media presence, and will steadily increase public market and investor communications.
As we shape the Company’s future operations to include a Digital Health and Regenerative Therapeutic division, we anticipate a “new corporate name” will soon be launched to support our significant progress and to best represent our evolving Company.
We are excited about the future of ORHub and look forward to increasing your share value. Thank you for your support.
Sincerely,
CJ Wiggins
Chairman & CEO
www.ORHub.com
